• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Ebata Takahiro  江畑 貴大

ORCIDConnect your ORCID iD *help
… Alternative Names

EBATA TAKAHIRO  江畑 貴大

Less
Researcher Number 80769620
Other IDs
Affiliation (Current) 2025: 星薬科大学, 先端生命科学研究所, 特任助教
2025: 国立研究開発法人国立がん研究センター, 中央病院, 外来研究員
Affiliation (based on the past Project Information) *help 2023: 星薬科大学, 先端生命科学研究所, 特任助教
2022: 星薬科大学, 薬学部, 特任助教
2020 – 2021: 国立研究開発法人国立がん研究センター, 研究所, 特任研究員
Review Section/Research Field
Principal Investigator
Basic Section 53010:Gastroenterology-related / Basic Section 56040:Obstetrics and gynecology-related
Keywords
Principal Investigator
DNAメチル化 / 大腸がん / 膵がん / 胃がん / 治療抵抗性 / BRCA1 / LRCOL1 / 卵巣がん
  • Research Projects

    (2 results)
  • Research Products

    (4 results)
  • Co-Researchers

    (3 People)
  •  FERMT2メチル化を利用したがん特異的なインテグリン経路阻害薬の開発Principal Investigator

    • Principal Investigator
      江畑 貴大
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53010:Gastroenterology-related
    • Research Institution
      Hoshi University
  •  Molecular profiling of the residual tumor of ovarian cancer after neoadjuvant chemotherapyPrincipal Investigator

    • Principal Investigator
      EBATA TAKAHIRO
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Hoshi University
      National Cancer Center Japan

All 2022 2021 2020

All Journal Article Presentation

  • [Journal Article] DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer2022

    • Author(s)
      Ebata Takahiro、Yamashita Satoshi、Takeshima Hideyuki、Yoshida Hiroshi、Kawata Yoshiko、Kino Nao、Yasugi Toshiharu、Terao Yasuhisa、Yonemori Kan、Kato Tomoyasu、Ushijima Toshikazu
    • Journal Title

      Gynecologic Oncology

      Volume: 167 Issue: 3 Pages: 513-518

    • DOI

      10.1016/j.ygyno.2022.10.008

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21H02773, KAKENHI-PROJECT-20K18180
  • [Journal Article] DNA methylation marker to estimate ovarian cancer cell fraction2022

    • Author(s)
      Ebata Takahiro、Yamashita Satoshi、Takeshima Hideyuki、Yoshida Hiroshi、Kawata Yoshiko、Kino Nao、Yasugi Toshiharu、Terao Yasuhisa、Yonemori Kan、Kato Tomoyasu、Ushijima Toshikazu
    • Journal Title

      Medical Oncology

      Volume: 39 Issue: 5 Pages: 78-78

    • DOI

      10.1007/s12032-022-01679-y

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21H02773, KAKENHI-PROJECT-20K18180
  • [Presentation] DNA methylation marker to estimate cancer cell fraction2021

    • Author(s)
      Ebata Takahiro
    • Organizer
      分子生物学会
    • Data Source
      KAKENHI-PROJECT-20K18180
  • [Presentation] Identification of Enhancer Methylation Associated with Treatment Resistance of Ovarian Cancer after Neoadjuvant Chemotherapy2020

    • Author(s)
      江畑貴大
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-20K18180
  • 1.  山下 聡
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 2.  竹島 秀幸
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 3.  牛島 俊和
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi